Literature DB >> 1482642

Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis.

F Schneble1, K E Bonzel, R Waldherr, S Bachmann, H Roth, K Schärer.   

Abstract

Fifty peritoneal biopsies (PB) from 35 patients with end-stage renal disease, treated by continuous ambulatory peritoneal dialysis (CAPD) and aged 2 months to 18 years, were examined by light microscopy (n = 50) and/or scanning electron microscopy. PB were performed during surgical procedures immediately before the start of, during, or after the cessation of CAPD treatment. PB from 15 children without renal disease undergoing laparatomy were examined similarly. Before the start of CAPD, a scarcity and shortening of the mesothelial microvilli was observed by scanning electron microscopy. During and after CAPD, variable alterations of mesothelium, interstitium and capillaries were found. The mesothelial layer was absent in all 5 PB obtained during episodes of active peritonitis. In patients treated by CAPD for longer than 6 months, mesothelial denudation was observed more frequently (6/11) than in children treated for shorter periods (1/7) (P < 0.08). Fibrosis of the peritoneal membrane was present in about 50% of patients during or after the cessation of CAPD without impairment of peritoneal function. No correlation was found between the presence of fibrosis and the frequency of peritonitis or the duration of CAPD treatment.

Entities:  

Mesh:

Year:  1992        PMID: 1482642     DOI: 10.1007/bf00866498

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

1.  Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.

Authors:  O Heimbürger; J Waniewski; A Werynski; A Tranaeus; B Lindholm
Journal:  Kidney Int       Date:  1990-09       Impact factor: 10.612

2.  Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients.

Authors:  J W Dobbie; J K Lloyd; C A Gall
Journal:  Adv Perit Dial       Date:  1990

3.  Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.

Authors:  C Verger; O Brunschvicg; Y Le Charpentier; A Lavergne; J Vantelon
Journal:  Proc Eur Dial Transplant Assoc       Date:  1981

4.  Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis.

Authors:  N Di Paolo; G Sacchi; M De Mia; E Gaggiotti; L Capotondo; P Rossi; M Bernini; A M Pucci; L Ibba; P Sabatelli
Journal:  Nephron       Date:  1986       Impact factor: 2.847

5.  Cytotoxicity of commercial peritoneal dialysis solutions towards peritoneal cells of chronically uremic mice.

Authors:  B Gallimore; R F Gagnon; M M Stevenson
Journal:  Nephron       Date:  1986       Impact factor: 2.847

6.  Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury.

Authors:  C Verger; A Luger; H L Moore; K D Nolph
Journal:  Kidney Int       Date:  1983-06       Impact factor: 10.612

7.  Case-control study to determine the cause of sclerosing peritoneal disease.

Authors:  R Oulès; S Challah; F P Brunner
Journal:  Nephrol Dial Transplant       Date:  1988       Impact factor: 5.992

8.  Peritoneal sclerosis in peritoneal dialysis patients.

Authors:  T S Ing; J T Daugirdas; V C Gandhi
Journal:  Am J Nephrol       Date:  1984       Impact factor: 3.754

9.  Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat.

Authors:  N D Slater; G H Cope; A T Raftery
Journal:  Nephron       Date:  1991       Impact factor: 2.847

10.  [Continuous ambulatory peritoneal dialysis (CAPD) in children and adolescents].

Authors:  K E Bonzel; O Mehls; D E Müller-Wiefel; L Diekmann; R Wartha; H Ruder; W Rascher; K Schärer
Journal:  Monatsschr Kinderheilkd       Date:  1986-04       Impact factor: 0.323

View more
  8 in total

1.  Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

Authors:  Anne-Catherine Raby; Chantal S Colmont; Ann Kift-Morgan; Jörg Köhl; Matthias Eberl; Donald Fraser; Nicholas Topley; Mario O Labéta
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

2.  Ultrasonographic evaluation of peritoneal membrane thickness and comparison with the effectiveness and duration of CAPD.

Authors:  Gokhan Temiz; Garip Sahin; Gul Mukerrem; Sultan Ozkurt; Nevbahar Akcar Degirmenci; Ahmet Ugur Yalcin
Journal:  Int Urol Nephrol       Date:  2013-07-25       Impact factor: 2.370

Review 3.  Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

4.  Effect of the dialysis fluid buffer on peritoneal membrane function in children.

Authors:  Claus Peter Schmitt; Barbara Nau; Gita Gemulla; Klaus E Bonzel; Tuula Hölttä; Sara Testa; Michel Fischbach; Ulrike John; Markus J Kemper; Anja Sander; Klaus Arbeiter; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-02       Impact factor: 8.237

5.  Quantitative Histomorphometry of the Healthy Peritoneum.

Authors:  Betti Schaefer; Maria Bartosova; Stephan Macher-Goeppinger; Akos Ujszaszi; Markus Wallwiener; Joanne Nyarangi-Dix; Peter Sallay; Dorothea Burkhardt; Uwe Querfeld; Viktoria Pfeifle; Bernd Lahrmann; Vedat Schwenger; Elke Wühl; Stefan Holland-Cunz; Franz Schaefer; Claus P Schmitt
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

6.  Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

Authors:  Jesús Loureiro; Guadalupe Gónzalez-Mateo; José Jimenez-Heffernan; Rafael Selgas; Manuel López-Cabrera; Abelardo Aguilera Peralta
Journal:  Int J Nephrol       Date:  2013-02-10

Review 7.  Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

8.  BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].

Authors:  Barbara Nau; Claus P Schmitt; Margarida Almeida; Klaus Arbeiter; Gianluigi Ardissino; Klaus E Bonzel; Alberto Edefonti; Michel Fischbach; Karin Haluany; Joachim Misselwitz; Markus J Kemper; Kai Rönnholm; Simone Wygoda; Franz Schaefer
Journal:  BMC Nephrol       Date:  2004-10-14       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.